Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT01081262||Active, not recruiting
|Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer||
||50||Female||18 Years and older (Adult, Older Adult)||NCT01081262||NCI-2011-02516
|October 12, 2010||February 25, 2015||March 5, 2010||June 18, 2019||March 18, 2019||